Invention Grant
- Patent Title: Substituted imidazoquinolines as agonists of TLR7
-
Application No.: US17669117Application Date: 2022-02-10
-
Publication No.: US11987569B2Publication Date: 2024-05-21
- Inventor: Christophe Henry
- Applicant: BIONTECH SE
- Applicant Address: DE Mainz
- Assignee: BIONTECH SE
- Current Assignee: BIONTECH SE
- Current Assignee Address: DE Mainz
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: WO TEP2017072353 2017.09.06
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07D401/04 ; C07D471/04
Abstract:
The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.
Public/Granted literature
- US20220242845A1 SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 Public/Granted day:2022-08-04
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
